Breaking News
0
Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% More details

U.S. seeks extradition of Chinese researcher in drug secrets theft

Stock MarketsJul 08, 2019 06:16AM ET
Saved. See Saved Items.
This article has already been saved in your Saved Items
 
© Reuters. U.S. seeks extradition of Chinese researcher in drug secrets theft

By John Miller

ZURICH (Reuters) - The United States wants Switzerland to extradite a Chinese researcher accused of helping his scientist sister steal secrets worth $550 million from drugmaker GlaxoSmithKline (L:GSK), Swiss documents released on Monday show.

Gongda Xue, who is fighting extradition, has been labeled a potential flight risk, according to a Swiss Federal Criminal Court verdict, keeping him in custody pending the extradition request's resolution.

U.S. allegations against Gongda Xue, 49, underscore global fears that China is using networks of highly trained nationals abroad to smuggle trade secrets to the world's second-largest economy.

Last year, prosecutors in Germany charged a Chinese-born engineer with industrial espionage in connection with secrets pilfered from chemical maker Lanxess (DE:LXSG).

Gongda Xue, a Basel-area scientist who worked at Switzerland's Friedrich Miescher Institute for Biomedical Research until 2014, is the brother of Yu "Joyce" Xue, a Chinese-American scientist who last August pleaded guilty at the U.S. District Court in Pennsylvania to pilfering secrets from Britain's GlaxoSmithKline (GSK).

According to the U.S. indictment, Gongda Xue received stolen GSK secrets from his sister, performed tests at Miescher's facilities and sent results to accomplices in China. The stolen information, prosecutors allege, involved antibodies that bind to tumour cells and kill them.

"Gongda Xue knowing received, bought, and possessed a trade secret belonging to GSK...knowing it to have been stolen...with the intent to convert that trade secret...to the economic benefit of someone other than GSK," according to one U.S. charge.

GSK said it was cooperating with U.S. authorities.

Xue, an 18-year Swiss resident, was arrested in May in Switzerland and has been held in custody as authorities consider the U.S. request, documents show.

"He faces up 20 years in prison if convicted," the Swiss court wrote, in rejecting his release. "We affirm a flight risk."

His Swiss lawyer declined to comment.

Yu Xue, his 48-year-old biochemist sister who worked at Glaxo in Pennsylvania until 2016, is awaiting sentencing in her case in which a U.S. government witness estimates secrets stolen were worth more than $550 million.

In total, there are six co-defendants, including Yu Xue's twin sister, Tian Xue, who also pleaded guilty last year to money laundering-related charges.

U.S. government lawyers allege the scheme included establishing a Chinese state-backed company, Renopharma, that relied on theft to bypass costly research that underpins drug development.

"GSK invested more than twenty years of work and hundreds of millions of dollars," U.S. prosecutors wrote. "By stealing these platforms, Renopharma obviated the need to undergo the same time and expense."

Prosecutors have branded the case "economic warfare", adding the group had profit motives and hoped to sell Renopharma for up to $2.2 billion.

Switzerland's Friedrich Miescher Institute, which helped develop cancer compounds such as Novartis's (S:NOVN) Afinitor, confirmed Gonda Xue had been a postdoctoral employee, adding the institute had not accused him of wrongdoing.

"We are cooperating with American authorities," an institute spokeswoman said.

U.S. seeks extradition of Chinese researcher in drug secrets theft
 

Related Articles

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Comments (2)
Chris Yeo
Chris Yeo Jul 08, 2019 8:51AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Dirty country and dirty methods.
Lloyd McCord
Lloyd McCord Jul 08, 2019 8:25AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I don't think it's possible for China to do such things. They're the most honest and respectful people in the world. This must be Trump's fault. Everyone steals from China, but China never steals from others. It's just not fair...
andrew dun
andrew dun Jul 08, 2019 8:25AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Could you sell me 50 cents of yuan?
Lloyd McCord
Lloyd McCord Jul 08, 2019 8:25AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
andrew dun  . Nope. I'm hanging on to all my yuan. It's gonna displace the dollar as the reserve currency any day now. Then I'll be rich!
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
or
Sign up with Email